DAVID L. BROWN MD.

Department:
STONY BROOK INTERNISTS

Board Certification:
American Board of Internal Medicine; Cardiovascular Medicine
American Board of Internal Medicine; Interventional Cardiology
American Board of Internal Medicine

Hospital Affiliations:
Stony Brook University Hospital

Clinical Practice Began:
1993

Gender:
Male

Best Doctor Lists
New York Magazine's Best Doctors
Top Doctors: New York Metro Area

Primary Medical Conditions Treated:

ANGINA
ANGIOPLASTY (CORONARY)
ANGIOPLASTY, NON-CORONARY
ARTERY (PERIPHERAL VASCULAR DISEASE)
CARDIAC CATHETERIZATION (CORONARY ANGIOGRAM)
CARDIAC DISEASES
CARDIOLOGY
CARDIOVASCULAR DYSFUNCTION
CLAUDICATION
CORONARY DISEASE
HEART FAILURE (CONGESTIVE HEART FAILURE)
RENAL ARTERY DISEASE
RENOVASCULAR HYPERTENSION
VALVULAR HEART DISEASE
VASCULAR

Education and Training

Medical School:
Baylor College of Medicine

Residency:
Baylor College of Medicine

Fellowship:
University of California, San Francisco
Cleveland Clinic

Academic

Year Appointed at Stony Brook:
2004

Academic Rank:
Professor

Insurance Plans

AETNA
AFFINITY HEALTH PLAN
AMERICHOICE
APA PARTNERS
BEECH STREET
BLUE CROSS/BLUE SHIELD HMO
BLUE CROSS/BLUE SHIELD OTHER PLANS
BLUE CROSS/BLUE SHIELD PPO
BLUE CROSS/BLUE SHIELD SENIOR PLAN
CIGNA HMO
CIGNA PPO
EMPIRE PLAN
FIDELIS CARE NEW YORK
GHI CBP
GHI HMO
HEALTH NET
HEALTHFIRST
HEALTHNET FEDERAL SERVICES (TRICARE)
HIP
ISLAND GROUP ADMINISTRATION
MAGNACARE
MEDICAID
MEDICARE
MULTIPLAN
OXFORD FREEDOM PLAN
SUFFOLK HEALTH PLAN
UNITED HEALTHCARE
VYTRA (except SMART START)

Practice Sites

DCI,

INTERNAL MEDICINE,
26 RESEARCH WAY,
EAST SETAUKET, NY 11733-3453.

Ph.: 631-444-0580
Fax

Fax: 631-444-0562

UNIV PHYS AT STONY BROOK - ISLANDIA,

INTERNAL MEDICINE,
3001 EXPRESSWAY DRIVE NORTH,
SUITE 200 B,
ISLANDIA, NY 11749-5301.

Ph.: 631-444-9600
Fax

Fax: 631-444-9621

My Notes

My practice philosophy is that by providing the highest quality, state-of-the-art care, patient outcomes will be enhanced.

My Articles

Berger JS, Vakili BA, Slater JN, Sherman W, Green SJ, Sanborn TA, Brown DL. Impact of platelet glycoprotein IIb/IIIa inhibitor therapy on in-hospital outcomes and long-term survival following percutaneous coronary rotational atherectomy. J Throm Thrombolysis 2005;19:47-54.
Moscucci M, Eagle KA, Share D, Smith D, DeFranco AC, O�Donnell M, Kline-Rogers E, Jani SM, Brown DL. Public reporting and case selection for percutaneous coronary interventions. J Am Coll Cardiol. 2005;45:1759-1765.
R Andraws, JS Berger, DL Brown. Effects of antibiotic therapy on outcomes of patients with coronary artery disease: A meta-analysis of randomized controlled trials. JAMA.2005;293:2641-2647.
Kaplan RC, Strickler HD, Rohan TE, Muzumdar R, Brown DL. Insulin-like growth factors and coronary heart disease. Cardiol Rev 2004;13: 35-39.
Kaplan RC, Bhalodkar NC, Brown EJ, White J, Brown DL. Race, ethnicity, and sociocultural characteristics predict noncompliance with lipid-lowering medications. Preventive Medicine 2004; 39:1249-1255.
Berger JS, Vakili BA, Sherman W, Sanborn TA, Brown DL. Influence of race on long-term survival following percutaneous coronary intervention. Am J Cardiol 2004; 94:647-649.
DL Brown (Editor), Cardiovascular Plaque Rupture, New York, Marcel Dekker, 2002.
DL Brown (Editor), Textbook of Cardiac Intensive Care, Philadelphia, W.B. Saunders Company, 1998.